Leelyn Smith’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$304K Buy
1,959
+112
+6% +$16.9K 0.03% 140
2026
Q2
$264K Hold
1,847
– – 0.03% 147
2026
Q1
$242K Hold
1,847
– – 0.03% 145
2025
Q4
$245K Hold
1,847
– – 0.04% 140
2025
Q3
$242K Hold
1,847
– – 0.04% 131
2025
Q2
$246K Hold
1,847
– – 0.04% 119
2025
Q1
$202K Hold
1,847
– – 0.04% 128
2024
Q4
$229K Sell
1,847
-75
-4% -$9.1K 0.04% 122
2024
Q3
$210K Sell
1,922
-70
-4% -$7.53K 0.04% 122
2024
Q2
$219K Hold
1,992
– – 0.04% 118
2024
Q1
$226K Buy
+1,992
New +$205K 0.05% 119
2023
Q1
– Sell
-240
Closed -$23.1K – 196
2022
Q4
$23.1K Buy
240
+100
+71% +$8.99K 0.01% 242
2022
Q3
$10K Sell
140
-2,500
-95% -$208K ﹤0.01% 286
2022
Q2
$210K Buy
2,640
+1,320
+100% +$116K 0.05% 119
2022
Q1
$129K Buy
1,320
+20
+2% +$1.89K 0.03% 137
2021
Q4
$121K Hold
1,300
– – 0.03% 147
2021
Q3
$122K Hold
1,300
– – 0.04% 143
2021
Q2
$125K Hold
1,300
– – 0.04% 144
2021
Q1
$117K Hold
1,300
– – 0.03% 157
2020
Q4
$104K Sell
1,300
-300
-19% -$22.3K 0.03% 160
2020
Q3
$105K Buy
+1,600
New +$105K 0.04% 158

Other funds holding EMR

Leelyn Smith's EMR Position: Q3 2026 in Review

Leelyn Smith increased its Emerson Electric (EMR) stake by 6.1% in Q3 2026, buying an estimated $16.9K and bringing the position to 1,959 shares worth $304K. The position accounts for 0.03% of the portfolio, ranked #140.

Leelyn Smith first reported a position in EMR in Q3 2020 and has held it in 21 quarters since. 1,647 funds tracked by Wall St. Rank hold EMR as of Q3 2026.

  • Leelyn Smith held 1,959 shares of Emerson Electric worth $304K as of Q3 2026.
  • Leelyn Smith bought 112 Emerson Electric shares in Q3 2026, an estimated $16.9K.
  • Emerson Electric made up 0.03% of Leelyn Smith's portfolio in Q3 2026, its #140 holding.
  • Leelyn Smith first reported a position in Emerson Electric in Q3 2020 and has held it in 21 quarters since.
  • 1,647 funds tracked by Wall St. Rank held Emerson Electric as of Q3 2026.

Based on Leelyn Smith's 13F filing for Q3 2026, filed 3 Nov 2026.